-
101
-
102
Daily Objective Physical Activity and Sedentary Time in Adults with COPD Using Spirometry Data from Canadian Measures Health Survey
Published 2018-01-01“…However, moderate to severe COPD participants (stages ≥2) had a significantly lower daily time spent in PA of moderate and vigorous intensity level compared to controls. …”
Get full text
Article -
103
The Meaning and Process of Pain Acceptance. Perceptions of Women Living with Arthritis and Fibromyalgia
Published 2008-01-01Get full text
Article -
104
Fibrous Myopathy as a Complication of Repeated Intramuscular Injections for Chronic Headache
Published 2006-01-01Get full text
Article -
105
Esophageal Involvement in Wegener’s Granulomatosis: A Case Report and Review of the Literature
Published 2000-01-01Get full text
Article -
106
Genomic characterization of noroviruses from an outbreak associated with oysters
Published 2025-02-01Get full text
Article -
107
Multifocal Gastric Neoplasia after Recurrent Laser Therapy for the Watermelon Stomach
Published 1997-01-01Get full text
Article -
108
-
109
-
110
Esophageal High Pressure Zones: Effect of Perisophageal Structures on Esophageal Manometric Recording
Published 1994-01-01Get full text
Article -
111
All That Bleeds Is Not Infliximab-Refractory Ulcerative Colitis
Published 2009-01-01Get full text
Article -
112
-
113
-
114
-
115
Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choice...
Published 2017-01-01“…Chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C) are common functional lower gastrointestinal disorders that impair patients’ quality of life. …”
Get full text
Article -
116
-
117
Posaconazole: A New Agent for the Prevention and Management of Severe, Refractory or Invasive Fungal Infections
Published 2008-01-01“…Posaconazole is the newest antifungal agent to be approved for use in Canada. With excellent in vitro activity against a broad spectrum of yeasts and filamentous fungi, as well as having a well-tolerated oral formulation, posaconazole offers many potential advantages. …”
Get full text
Article -
118
A case of pityriasis rubra pilaris secondary to ponatinib
Published 2025-01-01Get full text
Article -
119
-
120